Tracking Japan's development assistance for health, 2012-2016.,Globalization and Health

当前位置： X-MOL 学术 › Global. Health › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Tracking Japan's development assistance for health, 2012-2016.
Globalization and Health ( IF 10.8 ) Pub Date : 2020-04-15 , DOI: 10.1186/s12992-020-00559-2
Shuhei Nomura _{1,

2,

3} , Haruka Sakamoto _{1,

4} , Maaya Kita Sugai _{1,

3} , Haruyo Nakamura _{1,

3} , Keiko Maruyama-Sakurai _{3,

5} , Sangnim Lee _{6,

7,

8} , Aya Ishizuka _{1,

3,

9} , Kenji Shibuya ₁

Affiliation

Department of Global Health Policy, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
Department of Health Policy and Management, School of Medicine, Keio University, Tokyo, Japan.
Institute for Global Health Policy Research (iGHP), Bureau of International Health Cooperation, National Center for Global Health and Medicine, Tokyo, Japan.
Department of International Affairs and Tropical Medicine, Tokyo Women's Medical University, Tokyo, Japan.
Department of Clinical Epidemiology, Translational Medical Center, National Center of Neurology and Psychiatry, Tokyo, Japan.
Disease Control and Prevention Center, National Center for Global Health and Medicine, Tokyo, Japan.
Bureau of International Health Cooperation, National Center for Global Health and Medicine, Tokyo, Japan.
Department of Public Health, Graduate School of Medicine, Juntendo University, Tokyo, Japan.
School of Global Studies and Collaboration, Aoyama Gakuin University, Tokyo, Japan.

BACKGROUND Development assistance for health (DAH) is one of the most important means for Japan to promote diplomacy with developing countries and contribute to the international community. This study, for the first time, estimated the gross disbursement of Japan's DAH from 2012 to 2016 and clarified its flows, including source, aid type, channel, target region, and target health focus area. METHODS Data on Japan Tracker, the first data platform of Japan's DAH, were used. The DAH definition was based on the Organisation for Economic Co-operation and Development's (OECD) sector classification. Regarding core funding to non-health-specific multilateral agencies, we estimated DAH and its flows based on the OECD methodology for calculating imputed multilateral official development assistance (ODA). RESULTS Japan's DAH was estimated at 1472.94 (2012), 823.15 (2013), 832.06 (2014), 701.98 (2015), and 894.57 million USD (2016) in constant prices of 2016. Multilateral agencies received the largest DAH share of 44.96-57.01% in these periods, followed by bilateral grants (34.59-53.08%) and bilateral loans (1.96-15.04%). Ministry of Foreign Affairs (MOFA) was the largest contributors to the DAH (76.26-82.68%), followed by Ministry of Finance (MOF) (10.86-16.25%). Japan's DAH was most heavily distributed in the African region with 41.64-53.48% share. The channel through which the most DAH went was Global Fund to Fight AIDS, Tuberculosis, and Malaria (20.04-34.89%). Between 2012 and 2016, approximately 70% was allocated to primary health care and the rest to health system strengthening. CONCLUSIONS With many major high-level health related meetings ahead, coming years will play a powerful opportunity to reevaluate DAH and shape the future of DAH for Japan. We hope that the results of this study will enhance the social debate for and contribute to the implementation of Japan's DAH with a more efficient and effective strategy.

更新日期：2020-04-22

点击分享查看原文

点击收藏

公开下载

阅读更多本刊最新论文本刊介绍/投稿指南

全部期刊列表>>